Skip to content

Clinical trials

Terminated Phase 2 Astrocytoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Astrocytoma Phase: Phase 2 Status: Terminated Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20062
20081
20091
20102
20112
20121
20132
20142
20152
20161
20172
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Burzynski Research Institute3
University of California, San Francisco2
Ali Altunkaya1
Bernardino Clavo, MD, PhD1
Case Comprehensive Cancer Center1
Day One Biopharmaceuticals, Inc.1
Exelixis1
H. Lee Moffitt Cancer Center and Research Institute1
Harry T Whelan, MD1
Indiana University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Astrocytoma28
Glioblastoma20
Glioma17
Oligodendroglioma13
Brain Neoplasms9
Gliosarcoma7
Ependymoma3
Central Nervous System Neoplasms2
Diffuse Intrinsic Pontine Glioma2
Optic Nerve Glioma2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.